If you liked this article you might like

Roche Wins FDA Backing for New Multiple Sclerosis Therapy, Competition Could Crimp Biogen
Twitter, Netflix, MetLife: Doug Kass' Views
Why Concert Pharmaceuticals Is Music to Investors' Ears
Celgene Has Cure for Market Blues